In January 2024, the rare disease therapeutics sector experienced a funding surge to nearly $3 billion, indicating a strong start to the year.
In January 2024, the rare disease therapeutics sector experienced a funding surge to nearly $3 billion, indicating a strong start to the year.
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive